Rivastigmine Use in the Treatment of Antimuscarinic Delirium

J Med Toxicol. 2023 Jul;19(3):284-287. doi: 10.1007/s13181-023-00947-1. Epub 2023 May 19.
No abstract available

Keywords: Anticholinergic; Antimuscarinic; Cholinesterase inhibitor; Physostigmine; Rivastigmine.

Publication types

  • Letter

MeSH terms

  • Cholinesterase Inhibitors / adverse effects
  • Delirium* / drug therapy
  • Humans
  • Muscarinic Antagonists* / adverse effects
  • Physostigmine
  • Rivastigmine / adverse effects

Substances

  • Muscarinic Antagonists
  • Rivastigmine
  • Physostigmine
  • Cholinesterase Inhibitors